Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Glaveckaite, Sigita ^a   Valeviciene, Nomeda ^a   Palionis, Darius ^a   Puronaite, Roma ^a   Serpytis, Pranas ^a   Laucevicius, Aleksandras ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Cardiovascular magnetic resonance; Contractile reserve; Follow up studies; Functional improvement; Late gadolinium enhancement; Revascularisation

Indexed keywords

DOBUTAMINE; GADOLINIUM; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HEART STIMULATION; HUMAN; IMAGE ENHANCEMENT; LONG TERM CARE; LOW DRUG DOSE; MALE; MYOCARDIAL HIBERNATION; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PREDICTION; RADIOLOGICAL PARAMETERS; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; CHRONIC DISEASE; CONVALESCENCE; HEART CONTRACTION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; MIDDLE AGED; MYOCARDIAL STUNNING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; TIME; TISSUE SURVIVAL; TREATMENT OUTCOME;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; AGED; CHRONIC DISEASE; CONTRAST MEDIA; DOBUTAMINE; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL REVASCULARIZATION; MYOCARDIAL STUNNING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; STROKE VOLUME; TIME FACTORS; TISSUE SURVIVAL; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84910628559     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-014-0083-z     Document Type: Article

References (31)

1. Imaging techniques for the assessment of myocardial hibernation. Report of a study group of the European society of cardiology. SR Underwood, JJ Bax, J Vom Dahl, MY Henein, J Knuuti, AC van Rossum, ER Schwarz, JL Vanoverschelde, EE van der Wall, W Wijns, Eur Heart J 2004 25 10 815 36 10.1016/j.ehj.2004.03.012 15140530
2. The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era. BN Shah, RS Khattar, R Senior, Eur Heart J 2013 34 18 1323 36 10.1093/eurheartj/eht018 23420867
3. The heart failure revascularisation trial (HEART). JG Cleland, M Calvert, N Freemantle, Y Arrow, SG Ball, RS Bonser, S Chattopadhyay, MS Norell, DJ Pennell, R Senior, Eur J Heart Fail 2011 13 2 227 33 10.1093/eurjhf/hfq230 21156659
4. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). RS Beanlands, G Nichol, E Huszti, D Humen, N Racine, M Freeman, KY Gulenchyn, L Garrard, R de Kemp, A Guo, TD Ruddy, F Benard, A Lamy, RM Iwanochko, J Am Coll Cardiol 2007 50 20 2002 12 10.1016/j.jacc.2007.09.006 17996568
5. Myocardial viability and survival in ischemic left ventricular dysfunction. RO Bonow, G Maurer, KL Lee, TA Holly, PF Binkley, P Desvigne-Nickens, J Drozdz, PS Farsky, AM Feldman, T Doenst, RE Michler, DS Berman, JC Nicolau, PA Pellikka, K Wrobel, N Alotti, FM Asch, LE Favaloro, L She, EJ Velazquez, RH Jones, JA Panza, N Engl J Med 2011 364 17 1617 25 10.1056/NEJMoa1100358 21463153
6. Coronary-artery bypass surgery in patients with left ventricular dysfunction. EJ Velazquez, KL Lee, MA Deja, A Jain, G Sopko, A Marchenko, IS Ali, G Pohost, S Gradinac, WT Abraham, M Yii, D Prabhakaran, H Szwed, P Ferrazzi, MC Petrie, CM O'Connor, P Panchavinnin, L She, RO Bonow, GR Rankin, RH Jones, JL Rouleau, N Engl J Med 2011 364 17 1607 16 10.1056/NEJMoa1100356 21463150
7. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. RJ Kim, DS Fieno, TB Parrish, K Harris, EL Chen, O Simonetti, J Bundy, JP Finn, FJ Klocke, RM Judd, Circulation 1999 100 19 1992 2002 10.1161/01.CIR.100.19.1992 10556226
8. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. RJ Kim, E Wu, A Rafael, EL Chen, MA Parker, O Simonetti, FJ Klocke, RO Bonow, RM Judd, N Engl J Med 2000 343 20 1445 53 10.1056/NEJM200011163432003 11078769
9. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. JB Selvanayagam, A Kardos, JM Francis, F Wiesmann, SE Petersen, DP Taggart, S Neubauer, Circulation 2004 110 12 1535 41 10.1161/01.CIR.0000142045.22628.74 15353496
10. Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. O Bondarenko, AM Beek, JW Twisk, CA Visser, AC van Rossum, Eur Heart J 2008 29 16 2000 5 10.1093/eurheartj/ehn266 18556713
11. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. E Wellnhofer, A Olariu, C Klein, M Grafe, A Wahl, E Fleck, E Nagel, Circulation 2004 109 18 2172 4 10.1161/01.CIR.0000128862.34201.74 15117834
12. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation. S Glaveckaite, N Valeviciene, D Palionis, V Skorniakov, J Celutkiene, A Tamosiunas, G Uzdavinys, A Laucevicius, J Cardiovasc Magn Reson 2011 13 35 429 10.1186/1532-429X-13-35 21787383
13. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting-initial experience. CM Bove, JM DiMaria, S Voros, MR Conaway, CM Kramer, Radiology 2006 240 3 835 41 10.1148/radiol.2403051150 16926330
14. Combining magnetic resonance viability variables better predicts improvement of myocardial function prior to percutaneous coronary intervention. SW Kirschbaum, A Rossi, E Boersma, T Springeling, M van de Ent, GP Krestin, PW Serruys, DJ Duncker, PJ de Feyter, RJ van Geuns, Int J Cardiol 2012 159 3 192 7 10.1016/j.ijcard.2011.02.048 21414675
15. Revascularization in patients with chronic ischaemic myocardial dysfunction: insights from cardiovascular magnetic resonance imaging. O Bondarenko, AM Beek, GP McCann, AC van Rossum, Eur Heart J Cardiovasc Imaging 2012 13 12 985 90 10.1093/ehjci/jes194 23034989
16. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. JJ Bax, FC Visser, D Poldermans, A Elhendy, JH Cornel, E Boersma, A van Lingen, PM Fioretti, CA Visser, Circulation 2001 104 12 Suppl 1 314 8 11568075
17. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. F Haas, N Augustin, K Holper, M Wottke, C Haehnel, S Nekolla, H Meisner, R Lange, M Schwaiger, J Am Coll Cardiol 2000 36 6 1927 34 10.1016/S0735-1097(00)00968-2 11092666
18. Only hibernating myocardium invariably shows early recovery after coronary revascularization. B Shivalkar, A Maes, M Borgers, J Ausma, I Scheys, J Nuyts, L Mortelmans, W Flameng, Circulation 1996 94 3 308 15 10.1161/01.CIR.94.3.308 8759070
19. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. PR Knuesel, D Nanz, C Wyss, M Buechi, PA Kaufmann, GK von Schulthess, TF Luscher, J Schwitter, Circulation 2003 108 9 1095 100 10.1161/01.CIR.0000085993.93936.BA 12939229
20. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. JJ McMurray, S Adamopoulos, SD Anker, A Auricchio, M Bohm, K Dickstein, V Falk, G Filippatos, C Fonseca, MA Gomez-Sanchez, T Jaarsma, L Kober, GY Lip, AP Maggioni, A Parkhomenko, BM Pieske, BA Popescu, PK Ronnevik, FH Rutten, J Schwitter, P Seferovic, J Stepinska, PT Trindade, AA Voors, F Zannad, A Zeiher, Eur Heart J 2012 33 14 1787 847 10.1093/eurheartj/ehs104 22611136
21. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. MD Cerqueira, NJ Weissman, V Dilsizian, AK Jacobs, S Kaul, WK Laskey, DJ Pennell, JA Rumberger, T Ryan, MS Verani, Int J Cardiovasc Imaging 2002 18 1 539 42 12135124
22. Haug G. Stress echocardiography. 1998.
23. Operator induced variability in cardiovascular MR: left ventricular measurements and their reproducibility. MG Danilouchkine, JJ Westenberg, A de Roos, JH Reiber, BP Lelieveldt, J Cardiovasc Magn Reson 2005 7 2 447 57 10.1081/JCMR-200053578 15881528
24. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. F Grothues, GC Smith, JC Moon, NG Bellenger, P Collins, HU Klein, DJ Pennell, Am J Cardiol 2002 90 1 29 34 10.1016/S0002-9149(02)02381-0 12088775
25. StAR: a simple tool for the statistical comparison of ROC curves. IA Vergara, T Norambuena, E Ferrada, AW Slater, F Melo, BMC Bioinformatics 2008 9 265 2105 10.1186/1471-2105-9-265 18534022
26. Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement cardiovascular magnetic resonance. TJ Pegg, JB Selvanayagam, J Jennifer, JM Francis, TD Karamitsos, E Dall'Armellina, KL Smith, DP Taggart, S Neubauer, J Cardiovasc Magn Reson 2010 12 56 429 10.1186/1532-429X-12-56 20929540
27. Contractile reserve in segments with nontransmural infarction in chronic dysfunctional myocardium using low-dose dobutamine CMR. SW Kirschbaum, A Rossi, RT van Domburg, K Gruszczynska, GP Krestin, PW Serruys, DJ Duncker, PJ de Feyter, RJ van Geuns, JACC Cardiovasc Imaging 2010 3 6 614 22 10.1016/j.jcmg.2010.03.007 20541717
28. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. JJ Bax, AF Schinkel, E Boersma, A Elhendy, V Rizzello, A Maat, JR Roelandt, EE van der Wall, D Poldermans, Circulation 2004 110 11 Suppl 1 I18 22 15364832
29. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? AF Schinkel, D Poldermans, V Rizzello, JL Vanoverschelde, A Elhendy, E Boersma, JR Roelandt, JJ Bax, J Thorac Cardiovasc Surg 2004 127 2 385 90 10.1016/j.jtcvs.2003.08.005 14762345
30. Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction. R Senior, A Lahiri, S Kaul, Am J Cardiol 2001 88 6 624 9 10.1016/S0002-9149(01)01803-3 11564384
31. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. JS Pirolo, GM Hutchins, GW Moore, J Am Coll Cardiol 1986 7 2 349 54 10.1016/S0735-1097(86)80504-6 2935567